We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Treatment Helps Alleviate Tinnitus Symptoms

By HospiMedica International staff writers
Posted on 03 Dec 2013
A new method that pairs vagus nerve stimulation (VNS) with auditory tones can alleviate the symptoms of chronic tinnitus, according to a new study. More...


Researchers at University Hospital Antwerp (UZA; Belgium), the University of Texas (UT) Dallas (USA), and other institutions conducted a study involving ten patients with severe chronic tinnitus who were implanted with electrodes on their left vagus nerve. Two and a half hours each day for 20 days, the patients heard various tones, excluding the tinnitus-matched frequency, which was paired with brief electrical stimulation of the vagus nerve. The therapy was well tolerated, and no patient withdrew from the study due to complications or side effects.

The results showed that four of the ten patients exhibited clinically meaningful improvements in their tinnitus, both for the affective component (as quantified by the Tinnitus Handicap Inventory), and for the sound percept, as quantified by the minimum masking level. These improvements were stable for more than two months after the end of therapy. The researchers noted that of the ten patients, five were on medications that possibly interfered with acetylcholine and norepinephrine release induced by VNS, essential for inducing plasticity. These patients had no improvement, in contrast to medication-free patients. The study was published in the November 20, 2013, issue of the Neuromodulation.

“VNS […] involves sending a mild electric pulse through the vagus nerve, which relays information about the state of the body to the brain,” said study coauthor Sven Vanneste, MD, of the UZA Tinnitus Research Initiative Clinic. “VNS-tone therapy was expected to be safe because it requires less than 1% of the VNS approved by the FDA for the treatment of intractable epilepsy and depression. There were no significant adverse events in our study.”

Tinnitus is the perception of sound within the human ear when no actual sound is present. It is not a disease, but a condition that can result from a wide range of underlying causes, including neurological damage, ear infections, oxidative stress, foreign objects, nasal allergies, wax build-up, and exposure to loud sounds leading to noise-induced hearing loss. About 20% of people aged 55 to 65 years report symptoms on a general health questionnaire, and 11.8% on more detailed tinnitus-specific questionnaires.

Related Links:

University Hospital Antwerp
University of Texas (UT) Dallas



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.